Scope and Efficacy of Semaglutide in Metabolic Dysfunction-associated Steatohepatitis: A Critical Review of Recent Evidences
Raphael Ijeokwu, Tuoyo Stephen Fregene, Farzana Rahman, Sobner Aubourg, Venkateshwarlu Kamishetty, Tiffany Abbey, Cindy Onumajuru, Ediomo Ekabua, Nawazuddin Mohammed, Sorrentina Awala, Alfred Ochong Ikpe, Jyothsna Goranti, Claudiane Mouafo Madzoom, Chukwuma Alphonsus Chuma-Eze & Tagbo Onyemelukwe · Journal of Advances in Medicine and Medical Research · 2026
Metabolic dysfunction-associated steatohepatitis (MASH), formerly termed nonalcoholic steatohepatitis (NASH), is a progressive hepatic manifestation of systemic metabolic dysfunction and a growing cause of cirrhosis, hepatocellular carcinoma, and liver transplantation. Semaglutid...